Ameloblastic carcinoma: A systematic review

Abstract

AbstractBackgroundAmeloblastic carcinoma (AC) is the most common odontogenic malignancy, constituting approximately 30% of cases in this category. Literature is sparse on malignant odontogenic neoplasms, with a large proportion of current knowledge derived from case reports or small case series.MethodsA systematic review of case series/case reports of AC was conducted following the Preferred Reporting Items for Systematic Reviews and Meta‐analyses (PRISMA) Statement guidelines. Demographic and clinical information, including duration of the lesion, location, clinical presentation and radiologic features, were analysed. Additionally, the origin of the lesion (primary/secondary), Ki‐67 proliferation index, treatment performed, metastasis, tumour recurrence and prognosis were collected for analysis.ResultsA total of 126 studies, including 285 individual cases of AC, were included in this review. Patients presented with a near‐equal distribution of painless and painful swellings. ACs presented at a median age of 45 years, with a male‐to‐female ratio of 1:2. The mandible was most frequently involved, with rare cases extending to involve more than one region, including crossing the midline. Although most lesions presented with poorly‐demarcated borders (52.6%), unilocular lesions with well‐demarcated borders (47.4%) comprised a substantial number in the sample. The proliferation index was only reported in 27 cases, with a mean score of 42% and a wide range. The probability of tumour recurrence increased, and the survival probability decreased with prolonged follow‐up duration.ConclusionThis study provides more comprehensive, up‐to‐date descriptive data on these rare odontogenic malignancies, aiding clinicians and Pathologists with the diagnosis and surgeons in their management of cases.